Brightside Health
Virtual mental health provider offering therapy, psychiatry, and crisis care via insurance.
On the record
Checkpoint: DEA telehealth controlled-substance prescribing flexibilities expire
The call
Brightside holds the same regulatory protection as bigger rivals like Talkiatry, but thinner funding and a looming DEA prescribing deadline put it in a weaker spot to use that protection.
Brightside Health lets patients see psychiatrists and therapists online, then get prescriptions sent to their pharmacy. It is hard to copy because it needs real doctors, insurance contracts, and legal responsibility for patient safety, which takes years to build. However, Talkiatry does the same thing with more doctors and better insurance relationships, and Brightside is shrinking its staff and struggling to raise money, while a major rule allowing telehealth prescribing without visiting an office expires at the end of 2025 and may not come back. The company's next funding round will show whether it can survive or if it gets sold for parts.
Why
01
AI pressure: None apparent. AI speeds up triage and clinician workflow here, but licensed prescribers and suicide-risk liability keep AI-only tools out of this lane. Could AI do the core job? Unlikely.
02
Bigger players: Talkiatry. Talkiatry runs 800+ psychiatrists and 300+ therapists across roughly 60 health plans, outbuilding Brightside in the same insurance-based psychiatry lane. Could a giant copy it? Probably.
03
What protects it. Payer contracts, clinician licensure, and crisis-care liability rules that block easy copying by AI tools or unlicensed platforms.
What would change this call
Brightside announces a priced Series D or stays silent on financing through Q4 2026. Silence or bridge-only funding signals financial strain deepening toward a down-round or acquisition.
DEA telehealth controlled-substance prescribing rules lapse or tighten after Dec 31, 2025. Loss of prescribing flexibility would hit medication revenue across Brightside and rivals alike.
Talkiatry announces expansion into crisis or high-acuity psychiatry protocols. Would erase Brightside's remaining clinical differentiation in its core niche.
DEA telehealth controlled-substance prescribing rules lapse or tighten after Dec 31, 2025. Loss of prescribing flexibility would hit medication revenue across Brightside and rivals alike.
Talkiatry announces expansion into crisis or high-acuity psychiatry protocols. Would erase Brightside's remaining clinical differentiation in its core niche.
Key numbers
- Raised $33M Series C in March 2024
- Total funding to date around $109 to 123M
- Laid off staff in May 2025 amid funding gaps
Named risks
- DEA telehealth controlled-substance prescribing flexibilities only confirmed through Dec 31 2025, status after unclear.
- 2025 funding activity limited to small bridge-sized tranches rather than a priced round.
- May 2025 layoff of 36 employees signals cost pressure amid expansion into new service lines.
- Smaller clinical and payer footprint than better-resourced peer Talkiatry in the same insurance-psychiatry lane.
- No verified public revenue figures exist for Brightside Health as a private company.
Rivals, as read in July 2026
| Rival | Direction | Evidence |
|---|---|---|
| Talkiatry | gaining on | 800+ psychiatrists, 300+ therapists, in-network with ~60 health plans as of Feb 2026 |
| Talkspace | gaining on | Launched AI chatbot Tee for support functions in June 2026 |
| Cerebral | contesting | Acquired Resilience Lab in August 2025 despite a $7M FTC settlement in 2024 |
| BetterHelp (Teladoc) | contesting | Largest consumer online-therapy brand, expanding insurance acceptance as of 2026 |
| Lyra Health | contesting | Enterprise-focused behavioral health benefit competing for employer contracts as of 2026 |
Questions people ask
- Is Brightside Health profitable in 2026?
- No public evidence of profitability exists. Brightside Health is privately held with no audited revenue disclosed, and in May 2025 it cut 36 employees, mostly senior and non-clinical staff, a signal of cost pressure rather than growth-driven profitability as of mid-2026.
- Did Brightside Health have layoffs?
- Yes. On May 27, 2025, Brightside Health cut 36 employees, primarily senior support and non-clinical roles, according to Behavioral Health Business trade press, even as the company expanded into new programs like teen care and substance use disorder treatment.
- Who is Brightside Health's biggest competitor?
- Talkiatry is the closest structural competitor, operating in the same insurance-based virtual psychiatry lane with 800+ psychiatrists, 300+ therapists, and in-network status with roughly 60 health plans as of February 2026, a larger clinical and payer footprint than Brightside.
- Could AI replace Brightside Health's clinicians?
- No. Brightside's own August 2024 JMIR Mental Health study found GPT-4 comparable to clinicians in predicting suicidal ideation, but CMO Dr. Mimi Winsberg stated in December 2024 that clinical oversight remains paramount, positioning AI as augmentation for licensed prescribers, not a replacement.
- Who owns Brightside Health?
- Brightside Health is privately held and venture-backed, founded in November 2017 by Brad Kittredge and Dr. Mimi Winsberg. It has raised funding through Series A ($17M, 2021), Series B ($50M, 2022), and Series C ($33M, March 2024), with no IPO as of mid-2026.
- How much money has Brightside Health raised?
- Brightside Health raised a $17M Series A in February 2021, a $50M Series B in March 2022 led by ACME Capital and Mousse Partners, and a $33M Series C in March 2024 led by S32, bringing company-stated total funding to over $100M.
Timeline
- 2026-06Competitor Talkspace launches AI chatbot Tee for support functions
- 2025-08Competitor Cerebral acquires Resilience Lab
- 2025-05-27Brightside Health lays off 36 employees, mostly senior and non-clinical roles
- 2024-08Brightside publishes peer-reviewed GPT-4 crisis-prediction study in JMIR Mental Health
- 2024-06-12Brightside acquires Lionrock Recovery to add substance use disorder IOP
- 2024-03-26Brightside closes $33M Series C led by S32, total funding tops $100M
- 2023-10Brightside announces Medicare and Medicaid coverage expansion
- 2022-03Brightside closes $50M Series B led by ACME Capital and Mousse Partners
- 2021-02Brightside closes $17M Series A
- 2017-11Brightside Health founded by Brad Kittredge and Dr. Mimi Winsberg
Revision history
22 July 2026
First assessed. Losing its protection. The text above is fixed as of this date and is not edited afterwards.
In the same band
Sources
- Brightside | 2025-02-20 (2025-02-20)
- Brightside Health Raises $50 Million in Series B Funding (2023-01-03)
- Brightside Health Raises Strategic Series C (2024-03-26)
- Brightside Health Stock Price, Funding, Valuation, Revenue & Financial Statements (2025-07-24)
- Brightside Health Expands into Substance Use Disorder, Virtual Intensive Outpatient Treatment (2024-06-12)
- Brightside partnerships page (2025-02-25)
- Digital Behavioral Health Manufacturers and Recent Developments (2025-10-09)
- Brightside Health Number of Employees 2026 (2026-06-29)
- Brightside Health - Headcount, Funding & Open Jobs (2026-06-19)
- Exclusive: Brightside Health Cuts Jobs, Senior Employees Among Those Affected (2025-05-30)
- Brightside Best Alternatives for Each Use Case (2026-05-26)
- Large Language Models Versus Expert Clinicians in Crisis Prediction (2024-06-26)